Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Anacor Climbs on Atopic Dermatitis Treatment Study

By Pharmaceutical Processing | March 22, 2013

NEW YORK (AP) — Shares of Anacor Pharmaceuticals Inc. jumped Thursday after the company reported strong data from a clinical trial of a drug intended to treat a type of chronic rash.

Anacor is testing a topical drug called AN2728 as a treatment for atopic dermatitis, a chronic rash that causes inflammation and itching. It most often affects children. The company said patients improved over four weeks of treatment, with most of the gains coming in the first week. It tested two concentrations of AN2728 and plans to move the more concentrated form into late-stage studies.

Anacor Pharmaceuticals shares rose $1, or 26 percent, to close at $4.84. The stock added 36 cents, or 7.4 percent, to $5.20 in after-hours trading.

The trial involved 86 subjects aged 12 to 17. They were treated with one of the two concentrations either one or two times a day for four weeks. Improvement ranged from 54 percent for patients who used a less concentrated version once a day, to 71 percent for patients who used a stronger version twice a day.

The Palo Alto, Calif., company said side effects observed during the study were mild and mostly unrelated to AN2728.

 

Related Articles Read More >

Great Point Partners logo.
Great Point Partners acquires majority stake in Eutecma to fuel sustainable cold chain growth
Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE